A Veterinarian talks about Del-Immune V and pets – Part 1

Steve Sanderlin, DVM, is a veterinarian with holistic animal training. Dr. Sanderlin practices in Boulder County, Colorado, and attended veterinary school at Texas A&M. Dr. Sanderlin will answer questions about use of Del-Immune V® in animals, and can be contacted at SSandvm@aol.com

I’ve observed that with many animal health issues, there is an underlying compromised and depressed or low immune system. After being introduced to Del-immune V, I started recommending it for pets to provide immune support in conjunction with targeted treatment of many health issues. My clinical observation was that the product provided immediate immune support during all types of animal health issues, whether the condition was fungal, bacterial or viral.

In broad terms, we see a faster recovery rate with health issues when an animal’s immune system is supported with Del-Immune V. Another important characteristic I have observed is that this product modulates and balances rather than over-stimulating the immune system. This is important for animals with hyper-sensitivities. There are variables, but I have also seen the product help balance an over-active immune system.

Del-Immune V is ideal for immune support with many treatment protocols I recommend, and I have never observed side-effects from the product. I use it to support the immune system adjunctively during treatments including; cancer, ear and eye infections, respiratory tract infections and skin conditions to name a few. The product is cost effective and gives a big return for a small investment in a pet’s health.

Young puppies and kittens from shelters and mills frequently show up with respiratory infections and immune stress. Adding immune support to specific prescription treatment gets them back on track faster.

On the more life-threatening end of the spectrum, I see dogs with chronic, debilitating illness like cancer. I have observed that supporting the immune system with Del-Immune V during treatment helps the body fight cancer cells and also provides help with secondary immune problems relating to bacterial and fungal infections.

My best results are dose-related. For general maintenance in puppies and cats, I use half a capsule to a full capsule twice a day. For acute immune issues, smaller animals receive up to four capsules a day. With adult cat and small dogs, I suggest one to two capsules daily for maintenance, and up to six a day for immune support during acute problems. Medium and large dogs can have two capsules a day for maintenance and six to eight capsules a day during acute illness. I give very large dogs two Del-Immune V a day for maintenance, and up to four capsules twice a day during acute illness. Users can reduce doses after about two weeks.

The largest dose I’ve given for immune support was eight capsules a day to a chocolate lab with prostate cancer. In addition to cancer treatment, the dog’s immune system was supported with additional supplements and a grain-free diet. This pup had a high quality of life for more than a year after his diagnosis, in spite of the fact that dogs with this condition would typically live six months or less.

Questions about Del-Immune V and pets may be sent to SSAndvm@aol.com. You may also visit Dr. Sanderlin’s website at www.homeinsteadvetcare.com.

Research Confirms the Activity of Del-Immune V®

In 2007, Pure Research Products, maker of Del-Immune V® sponsored a variety of research products. One of these projects was conducted at the Institute of Microbiology in Kiev, Ukraine. The results of the project were described in a research paper titled, “Study of Interferogenous Activity of Del-Immune V®.” The principal author, Dr. Nicoli Spivak is a distinguished professor and recognized authority on the function of the immune system.

When we originally visited Dr. Spivak in early 2007, he immediately became interested in the product and suggested measuring natural interferon activity in laboratory animals. Natural interferons are very important substances in the immune system. Their function is to activate cells that protect us from viruses, bacteria, the formation of tumor cells and to fight foreign invaders.

The primary interferons are identified as alpha, beta and gamma. TNF, or tumor necrosis factor, was also measured. All of these important  immune components work together to help keep us healthy and free of infection and disease. Interferons alpha and beta are primarily anti-viral and anti-tumor, and TNF is anti-bacterial and anti-tumor.

In his research, Dr. Spivak used five groups  of laboratory animals. Three of the groups received oral Del-Immune V® in different dosages; one group received a known research product and a fifth group received saline. All of the products were administered by mouth. The details of this research project are much more complex, but the research paper summarizes the results this way:

Del-Immune V® increased interferon production levels by two and a half to three times and interferon levels were raised by two times compared to the research standard.

Dr. Spivak also found that the administration of Del-Immune V® leads to an immediate immune response after eight hours, and TNF levels are increased after one hour. Repeating the dosage increased levels of interferons for up to three days. Tumor necrosis factor levels were 10 times higher than the saline control group.

Dr. Spivak concluded that Del-Immune V® demonstrated broad spectrum immune properties. He confirmed that Del-Immune V® does provide immediate immune support, and that it works fast.

To learn more about how Del-Immune V® can provide immediate immune system support, click here.

Chemo Patients Report Fewer Side-Effects with Del-Immune V® Supplements

Elin Ritchie, M.D. is a medical doctor trained in Canada at the University of Manitoba in Winnipeg. She graduated from medical school in 1992, and from a family practice residency program in 1994. She is a Board Certified member of the American College of Family Practice (ACFP).

Approximately three months after I opened my practice in 2003, I saw a new patient complaining of fatigue, weight loss, inability to concentrate and very low energy. That day, talking with her in the office and examining her, I discovered that she had a tumor in her pelvis the size of a grapefruit. Further tests indicated that she had ovarian cancer.

In a long discussion with her, we outlined different possibilities for treatment and further diagnosis. I suggested Del-Immune V® right away to combat her fatigue. On the day of her surgery, about two weeks later, I spoke to her. She said that her energy had increased and that she was feeling strong and ready to go through the surgery. Even though the surgeon was able to remove her tumor, ovarian cancer has a very poor cure rate; with all conventional medical treatments, patients have about a 30 percent survival rate after the first three years.

After surgery, the patient elected to continue with alternative therapies rather than chemo and radiation. She took some herbs, followed a dietary program and continued a daily supplement of Del-Immune V® throughout the first year after her diagnosis. When rechecked one year later, all evidence of the cancer was gone, all blood tests were clear and her pelvic exam was normal. This is only one case, but it has been remarkable to see such a dramatic recovery right in front of my eyes.

As far as radiation and chemotherapy treatment go, in my experience, patients who take supplements of Del-Immune V® experienced less sickness directly related to the treatments while not impacting their effectiveness. I have recommended it often in patients with cancer; some of them continue with regular medical therapies and use Del-Immune V® along with the chemotherapy or other treatments as planned.

To find out more about how Del-Immune V® works, click here.

Cancer, chemotherapy and radiation in my medical practice

Elin Ritchie, M.D. is a medical doctor trained in Canada at the University of Manitoba in Winnipeg. She graduated from medical school in 1992, and from a family practice residency program in 1994. She is a Board Certified member of the American College of Family Practice (ACFP). Dr. Ritchie currently practices integrative medicine in Taos, New Mexico.

Approximately three months after I opened my practice in 2003, I saw a new patient complaining of fatigue, weight loss, inability to concentrate and very low energy. That day, talking with her in the office and examining her, I discovered that she had a tumor in her pelvis the size of a grapefruit. Further tests indicated that she had ovarian cancer.

In a long discussion with her, I outlined different possibilities for treatment and further diagnosis. I immediately put her on Del-Immune V® at a fairly high dose. Two weeks later, on the day of her surgery, I spoke to her. She said that her energy had increased and that she was feeling strong and ready to go through the surgery. The planned surgery was very long and complicated, one in which it was possible that they would remove not only the tumor, but also part of her intestine, which would leave her wearing a colostomy bag. She was not looking forward to that, but she was willing to do whatever was necessary to remove the tumor. As it turned out, the tumor was easily removed without having to remove any intestine. When I spoke to her surgeon just after her surgery, he said he was surprised; it appeared that the tumor has started to pull away from the surrounding tissue and that the outer layer of the tumor had started to dissolve. He said that the tumor appeared to have shrunk prior to the surgery.

This patient chose alternative treatment for the ovarian cancer. Here I should tell you that ovarian cancer has a very poor cure rate; with all conventional medical treatments, success rates are extremely low. Patients have about a 30 percent survival rate after the first three years and they don’t count after five years because almost no one makes it.

Given the terrible odds of treatment, this patient decided to go with alternative therapies only. She took some herbs, followed a dietary program, and most importantly, stayed on high doses of Del-Immune V® throughout the first year after her diagnosis. When rechecked one year later, all evidence of the cancer was gone, all blood tests were clear and her pelvic exam was normal. It was as if nothing had happened. The other day I ran into her at the grocery store, as often happens in a small town. I invited her to come back to the office for evaluation. My recent evaluation with her a full three years after her diagnosis showed no evidence of any illness whatsoever. This is only one case, but it has been very dramatic to see such a miraculous event right in front of my eyes.

I have one patient who was diagnosed with prostate cancer at a very high level of bony metastasis. He has now lived for 18 months, and he is on a slow decline; however, when I first met him and saw how high his PSA levels were, I did not expect him to live more than an additional three to six months, no matter what therapies were applied.

As far as radiation and chemotherapy treatment go, in my experience, Del-Immune V® lessened the sickness directly related to the treatments while not impacting their effectiveness. I have used it often in patients with cancer, some of them continue with regular medical therapies and use Del-immune V along with the chemotherapy or whatever else is planned. My patients have been happy to use Del-immune V during chemo and radiation because they tolerate their treatments so much better than without the product. I believe that when clinical studies are done, we will see that Del-Immune V® increases the effectiveness of chemotherapy and radiation on diseased tissue while decreasing the “die-off” of healthy tissue. In effect, Del-Immune V® probably concentrates the treatment to diseased cells.

To find out more about how Del-Immune V® works, click here.